Safety and tolerability of ribosome-component immune modulator in adults and children

Allergy and Asthma Proceedings

Volumn 30, Issue 4 SUPPL. 1, 2009, Pages

  Olivieri, Dario ^a   Fiocchi, Alessandro ^b   Pregliasco, Fabrizio ^c   Veehof, Suzanne ^b   Cantoni, Vittorio ^d   Marcassa, Sergio ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b Melloni Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Istituto Lusofarmaco d'Italia   (Italy)

^e Medical Marketing Department   (Italy)

Author keywords

Adverse reactions; Bacterial extracts; Contraindications; Drug interactions; Pharmacovigilance; Postmarketing; Ribosomal component immune modulator (RCIM); Safety; Side effects; Tolerability profile

Indexed keywords

IMMUNOMODULATING AGENT; NOSE SPRAY; PLACEBO; RIBOSOME COMPONENT IMMUNE MODULATOR; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE GLOMERULONEPHRITIS; ASTHENIA; AUTOIMMUNE DISEASE; BRONCHITIS; CHILL; CHRONIC TONSILLITIS; CLINICAL TRIAL; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG FEVER; DRUG FORMULATION; DRUG HYPERSENSITIVITY; DRUG MARKETING; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DYSURIA; ERYTHEMA MULTIFORME; GYNECOMASTIA; HUMAN; HYPERTHERMIA; IMMUNOSTIMULATION; LOWER RESPIRATORY TRACT INFECTION; MACULOPAPULAR RASH; OTITIS MEDIA; PRESCRIPTION; PRURITUS; RECURRENT PHARYNGOTONSILLITIS; RECURRENT RESPIRATORY INFECTION; RECURRENT UPPER AIRWAY INFECTION; RECURRENT UPPER AND LOWER AIRWAY INFECTION; RESPIRATORY TRACT INFECTION; REVIEW; RHINITIS; RISK ASSESSMENT; TONSIL DISEASE; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VIRUS INFECTION;

ADULT; AGED; ANTIGENS, BACTERIAL; CHILD; DRUG EVALUATION; GLOMERULONEPHRITIS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOLOGIC FACTORS; PRODUCT SURVEILLANCE, POSTMARKETING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RESPIRATORY TRACT INFECTIONS; VACCINATION; VIRUS DISEASES;

EID: 68949083066     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3247     Document Type: Review

References (20)

1. Brunetti L, Francavilla R, Tesse R, et al. Effects of oral bacterial immunotherapy in children with atopic eczema/dermatitis syndrome: A pilot study. BioDrugs 19:393-399, 2005. (Pubitemid 43060722)
2. Bystron J, Hermanova Z, Heller L, and Pazderova D. Comparison of the effects of ribosomal immunotherapy on plasma levels of total IgE and cytokines IL-4, IL-5, IL-12 and IFN gamma in adult atopic and non-atopic patients during the pollen season. Clin Drug Invest 24:755-760, 2004. (Pubitemid 39665440)
3. Giovannini M, Fiocchi A, Sala M, et al. Immucytal in the prevention and treatment of recurrent upper respiratory tract infections in children: A randomized, placebo-controlled, double-blind study. Int J Immunother 16:67-75, 2000. (Pubitemid 32294088)
4. Mora R, Dellepiane M, Crippa B, et al. Ribosomal therapy in the prophylaxis of recurrent pharyngotonsillitis in children. Int J of Pediat Otorhinolaryngol 71:257-261, 2007. (Pubitemid 46075151)
5. Galioto GB, Galioto P, Mevio E, et al. Efficacy and tolerability of immucytal in the prevention and treatment of respiratory tract infections in adults: A randomized, placebo-controlled, double-blind study. Int J Immunother XVII:31-40, 2001. (Pubitemid 33133970)
6. Huls VG, Welbers P, and Lindemann H. Immunotherapie bei kindern mit hilfe eines multibakteriellen ribosmenpraparates. Der Kinderartz 26:1018-1024, 1995.
7. Lacomme Y, Narcy P. Prévention par immunotherapie ribosomale des épisodes de surinfection récidivante de la sphère ORL chez l'enfant. Immunol Med 11:73-75, 1985.
8. Fiocchi A, Vignati B, Cinquepalmi P, at al. Terapia con Immucytal di bambini affetti da infezioni respiratorie recidivanti: Esperienza italiana policentrica. Ped Med Chir 11:1-8, 1989.
9. Haguenauer JP. Prévention des épisodes infectieux récidivants de la sphère ORL par Ribomunyl comprimés chez l'enfant de moins de 5 ans. Immunol Med 18:36-39, 1987.
10. Debas J. Relapsing tonsillitis prevention with a ribosomial vaccine. Otorhinolaryngol Head Neck Surg. Proceedings of the XIV World Congress of Otorhinolaryngology, Head and Neck Surgery, Madrid, Spain, September 10-15, 1989. Sacristàn T, Alvarez-Vicent JJ, Antolf-Candela F (eds.). Kugler & Ghedini Publications, Amsterdam, Berkeley, Milano, 1990. 2883-2885.
11. Garabedian EN, Dubreuil C, and Triglia JC. Effectiveness and tolerance of Ribomunyl tablets in preventing middle ear infections in children affected by SOM. International Congress on Prevention of Infection, Nice, France, 1990 (Data on file).
12. Guerin JC, Leophonte P, Nuir JF, et al. Prevention of bronchial superinfections in chronic bronchitis patients with Ribomunyl tablets. CIPI 1990, Pierre Fabre Medicament, Castres.
13. Fiocchi A, Arancio R, Cinquepalmi P, et al. Recurrent respiratory infections in childhood experience with a bacterial extract plus bacterial ribosomes (Immucytal). J Int Med Res 18:50-60, 1990. (Pubitemid 20052137)
14. Vautel JM, Cauquil J, Perruchet AM, et al. Prevention of recurrent ear, nose, and throat infections in young children with Ribomunyl: double-blind placebo-controlled study. Curr Ther Res 53:722-729, 1993. (Pubitemid 23261649)
15. Serrano E, Demanez JP, Morgon A, et al. Effectiveness of ribosomal fractions of Klebsiella pneumoniae, Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and the membrane fraction of Kp (Ribomunyl) in the prevention of clinical recurrences of infectious rhinitis. Results of a multicenter double-blind placebo-controlled study. Eur Arch Otorhinolaryngol 254:372-375, 1997.
16. Gramiccioni E, Girbino G, and Pelucco D. Efficacy and tolerability of Immucytal in the prevention of upper respiratory tract infections: A randomised, placebo-controlled, double-blind study. J Clin Res 4:53-63, 2001. (Pubitemid 32916718)
17. Mora R, Barbieri M, Passali GC, et al. A preventive measure for otitis media in children with upper respiratory tract infections. J Pediatr Otorhinolaryngol 63:111-118, 2002. (Pubitemid 34296511)
18. Mora R, Ralli G, Passali FM, et al. Short ribosomal prophylaxis in the prevention of clinical recurrences of chronic otitis media in children. Int J Pediatr Otorhinolaryngol 68:83-89, 2004.
19. Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, et al. Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev 18:CD004974, 2006. (Pubitemid 46841223)
20. Periodic Safety Update Report Ribomunyl (Ribomunyl bacterial ribosomes + membrane fraction. Tablets, granules, freeze-dried product + solvent, suspension for inhalation) January 1, 2000-November 2, 2006.